{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:11:48Z","timestamp":1792005108102,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007655.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T00:00:00Z","timestamp":1482278400000}}],"reference-count":78,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007655.pub3","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T23:48:02Z","timestamp":1482277682000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Blood pressure-lowering efficacy of reserpine for primary hypertension"],"prefix":"10.1002","volume":"2016","author":[{"given":"Sandy D","family":"Shamon","sequence":"first","affiliation":[{"name":"Medical Clinic; 11 George St South Cambridge ON Canada N1S 2N3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco I","family":"Perez","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 2176 Health Science Mall Vancouver BC Canada V6T 1Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,12,21]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD007655.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.0954-6820.1957.tb14448.x","article-title":"Hypotensive effect of reserpine compared with phenobarbital and placebo","volume":"157","author":"Kfogsgaard","year":"1957","journal-title":"Acta Medica Scandinavica"},{"issue":"21","key":"10.1002\/14651858.CD007655.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM195705232562102","article-title":"Technic of controlled drug assay illustrated by a comparative study of Rauwolfia serpentina, phenobarbital and placebo in the hypertensive patient","volume":"256","author":"Shapiro","year":"1957","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007655.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archinte.1960.03820010083013","article-title":"A double blind control study of antihypertensive agents. I. Comparative effectiveness of reserpine, reserpine and hydralazine, and three ganglionic blocking agents, chlorisondamine, mecamyamine, and pentolinium tartrate","volume":"106","author":"Veterans Administration Cooperative Group (VACS)","year":"1960","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub3-BIB0004|cit4","first-page":"395","article-title":"A randomized double-blind study of furosemide-reserpine in essential hypertension","volume":"18","author":"Velasco","year":"1975","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"9","key":"10.1002\/14651858.CD007655.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.1955.02960260011004","article-title":"Hypertension treated with Rauwolfia serpentina and with reserpine; controlled study disclosing occasional severe depression","volume":"159","author":"Achor","year":"1955","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00000441-195608000-00010","article-title":"Reserpine as an antihypertensive in the outpatient clinic, a double blind clinical study","volume":"232","author":"Bello","year":"1956","journal-title":"The American Journal of the Medical Sciences"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub3-BIB0007|cit7","first-page":"614","article-title":"Efficacy of Rauwolfia serpentina preparations in the treatment of hypertension in general medical practice: a clinical comparison of three regimens","volume":"7","author":"Christman","year":"1956","journal-title":"American Practitioner and Digest of Treatment"},{"key":"10.1002\/14651858.CD007655.pub3-BIB0008|cit8","first-page":"1420","article-title":"Anti-hypertensive effects of chlorothiazide, reserpne and placebo. A double-blind evaluation","volume":"60","author":"Johnson","year":"1961","journal-title":"Michigan State Medical Society"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-44-3-456","article-title":"Reserpine-hydralazine combination therapy of hypertensive disease, with hydralazine in doses generally below the toxic range","volume":"44","author":"Lee","year":"1956","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD007655.pub3-BIB0010|cit10","first-page":"1323","article-title":"The hypotensive action of Rauwolfia serpentina and reserpine: a double hidden placebo study of ambulatory patients with hypertension","volume":"6","author":"Palmer","year":"1955","journal-title":"American Practitioner and Digest of Treatment"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/01.CIR.16.2.200","article-title":"Effect of Rauwolfia serpentina and reserpine on the blood pressure in essential hypertension; a long-term double-blind study.","volume":"16","author":"Sheldon","year":"1957","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD007655.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/000331976001100503","article-title":"A double blind evaluation of the antihypertensive effect of reserpine, phenobarbital, hydralazine, syrosingopine, and placebo in ambulatory subjects","volume":"11","author":"Sosa","year":"1960","journal-title":"Angiology"},{"issue":"11","key":"10.1002\/14651858.CD007655.pub3-BIB0013|cit13","first-page":"509","article-title":"Comparison of Rauwolfia drugs in treatment of hypertension","volume":"11","author":"Suckle","year":"1956","journal-title":"Geriatrics"},{"issue":"5360","key":"10.1002\/14651858.CD007655.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/bmj.2.5360.781","article-title":"Methyldopa and hydrochlorothiazide compared with reserpine and hydrochlorothiazide in hypertension","volume":"2","author":"Agnew","year":"1963","journal-title":"British Medical Journal"},{"issue":"23","key":"10.1002\/14651858.CD007655.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD007655.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1476-5381.1959.tb00936.x","article-title":"Mechanism of action of reserpine in producing gastric haemorrhage and erosion in the mouse","volume":"14","author":"Blackman","year":"1959","journal-title":"British Journal of Pharmacology and Chemotherapy"},{"issue":"23","key":"10.1002\/14651858.CD007655.pub3-BIB0017|cit17","first-page":"1113","article-title":"Clinical-pharmacologic studies and therapy with anti-hypertensive furosemide-reserpine preparations","volume":"66","author":"Bracharz","year":"1971","journal-title":"Medizinische Klinik"},{"issue":"8","key":"10.1002\/14651858.CD007655.pub3-BIB0018|cit18","first-page":"348","article-title":"Rauwolfia serpentina in essential hypertension","volume":"86","author":"Chakravarty","year":"1951","journal-title":"Indian Medical Gazette"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00803450","article-title":"Experimental investigation of the mechanism of action of reserpine","volume":"73","author":"Chekman","year":"1972","journal-title":"Bulletin of Experimental Biology and Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub3-BIB0020|cit20","first-page":"773","article-title":"Atenolol, chlorthalidone, and reserpine in mild-moderate hypertension: double-blind comparison","volume":"7","author":"Divitiis","year":"1981","journal-title":"Drugs Under Experimental & Clinical Research"},{"issue":"6822","key":"10.1002\/14651858.CD007655.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(54)92152-2","article-title":"Hypotensive action of reserpine","volume":"266","author":"Doyle","year":"1954","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub3-BIB0022|cit22","first-page":"233","article-title":"Comparative efficacy of reserpine and guanethidine in thiazide-treated patients with mild to moderate essential hypertension","volume":"17","author":"Ferguson","year":"1975","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD007655.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.54.1.32","article-title":"Patient acceptance of guanethidine as therapy for mild to moderate hypertension. A comparison with reserpine","volume":"54","author":"Ferguson","year":"1976","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD007655.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9343(54)90022-4","article-title":"The value of rauwolfia serpentine in the hypertensive patient","volume":"17","author":"Finnerty","year":"1954","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.1979.03290320021022","article-title":"Step 2 regimens in hypertension. An assessment","volume":"241","author":"Finnerty","year":"1979","journal-title":"JAMA"},{"issue":"5-6 Pt 1","key":"10.1002\/14651858.CD007655.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/009127008002000509","article-title":"Chlorthalidone plus reserpine versus hydrochlorothiazide plus reserpine in a stepped-care approach to the treatment of essential hypertension","volume":"20","author":"Finnerty","year":"1980","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD007655.pub3-BIB0027|cit27","first-page":"56p","article-title":"The clinical effectiveness of dihydroergocristine - reserpine clopamide combination in the treatment of hypertension","volume":"17th Scientific","author":"Gaskin","year":"Bahamas 1972","journal-title":"Standing Advisory Committee for Medical Research in the British Caribbean"},{"issue":"9","key":"10.1002\/14651858.CD007655.pub3-BIB0028|cit28","first-page":"561","article-title":"Reserpine, hydralazine, hydrochlorothiazide combination(Ser-AP-ES) in essential hypertension","volume":"14","author":"Glazer","year":"1972","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"5","key":"10.1002\/14651858.CD007655.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/08037059709062086","article-title":"Low-dose reserpine\/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor","volume":"6","author":"Griebenow","year":"1997","journal-title":"Blood Pressure"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003823.pub2","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub3-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003822.pub2","article-title":"Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension","author":"Heran","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00000441-195502000-00001","article-title":"Treatment of hypertension with oral reserpine alone and in combination with hydralazine and hexamethonium","volume":"229","author":"Hughes","year":"1955","journal-title":"The American Journal of the Medical Sciences"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub3-BIB0033|cit33","first-page":"1097","article-title":"Therapeutic efficacy of oxprenolol in essential hypertension: a double-blind comparison with reserpine","volume":"6","author":"INAGAKI","year":"1978","journal-title":"Japanese Pharmacology and Therapeutics"},{"issue":"6050","key":"10.1002\/14651858.CD007655.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1136\/bmj.2.6050.1476","article-title":"Mild hypertension: a clinical trial conducted in hospital general practice","volume":"2","author":"Joesbury","year":"1976","journal-title":"British Medical Journal"},{"issue":"7303","key":"10.1002\/14651858.CD007655.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"11","key":"10.1002\/14651858.CD007655.pub3-BIB0036|cit36","first-page":"3796","article-title":"Clinical efficacy of apllobal for essential hypertension: a multicenter double-blind controlled comparison with reserpine","volume":"54","author":"Kanda","year":"1977","journal-title":"The Japanese Journal of Clinical and Experimental Medicine"},{"issue":"8","key":"10.1002\/14651858.CD007655.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/jps.2600600805","article-title":"Antihypertensive properties of cryptenamine used with reserpine and methyclothiazide","volume":"60","author":"Kennedy","year":"1971","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.0954-6820.1958.tb01792.x","article-title":"The role of reserpine in essential hypertension when used alone or combined with hydralazine","volume":"162","author":"Krogsgaard","year":"1958","journal-title":"Acta Medica Scandinavica"},{"issue":"27","key":"10.1002\/14651858.CD007655.pub3-BIB0039|cit39","first-page":"1198","article-title":"Antihypertensive combination-therapy with inositol nicotinate in essential hypertension","volume":"28","author":"Kr\u00e4mer","year":"1977","journal-title":"Die Medizinische Welt"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/01.HYP.29.2.651","article-title":"Different concepts in first-line treatment of essential hypertension. Comparison of a low-dose reserpine-thiazide combination with nitrendipine monotherapy. German Reserpine in Hypertension Study Group","volume":"29","author":"Kr\u00f6nig","year":"1997","journal-title":"Hypertension"},{"issue":"37-8","key":"10.1002\/14651858.CD007655.pub3-BIB0041|cit41","first-page":"930","article-title":"Comparative clinical studies on the effect of hydrazine phthalazine and the rauwolfia alkaloid reserpine on blood pressure","volume":"32","author":"Kuhns","year":"1954","journal-title":"Klinische Wochenschrift"},{"issue":"1-2","key":"10.1002\/14651858.CD007655.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0021-9681(79)90021-3","article-title":"Methodological variation in case-control studies of reserpine and breast cancer","volume":"32","author":"Labarthe","year":"1979","journal-title":"Journal of Chronic Diseases"},{"issue":"7404","key":"10.1002\/14651858.CD007655.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub3-BIB0044|cit44","first-page":"1224","article-title":"Antihypertensive effects of clopamide administered alone in combination with pindolol or with reserpine and dihydroergocristine","volume":"46","author":"Leary","year":"1989","journal-title":"Current therapeutic Research, Clinical and Experimental"},{"issue":"5","key":"10.1002\/14651858.CD007655.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM195708012570507","article-title":"Effect of varying doses of reserpine on gastric secretion","volume":"257","author":"Liebowitz","year":"1957","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD007655.pub3-BIB0046|cit46","first-page":"344","article-title":"A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension","volume":"43","author":"Manyemba","year":"1997","journal-title":"The Central African Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD007655.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1001\/jama.1977.03270480043018","article-title":"Propranolol in the treatment of essential hypertension","volume":"237","author":"Mattes","year":"1977","journal-title":"Journal of the American Medical Association"},{"issue":"11","key":"10.1002\/14651858.CD007655.pub3-BIB0048|cit48","first-page":"683","article-title":"Double-blind cross-over study of the hypotensive action of reserpine alone and associated with a diuretic (mebutizide)","volume":"53","author":"Nicaise","year":"1973","journal-title":"Bruxelles Medical"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub3-BIB0049|cit49","first-page":"844","article-title":"Diltiazem for treatment of essential hypertension: a double-blind controlled study with reserpine","volume":"6","author":"Ogawa","year":"1984","journal-title":"Clinical Therapeutics"},{"issue":"214","key":"10.1002\/14651858.CD007655.pub3-BIB0050|cit50","first-page":"194","article-title":"Treatment of hypertension with quinethazone alone or in combination with reserpine","volume":"203","author":"Parkes","year":"1969","journal-title":"The Practitioner"},{"key":"10.1002\/14651858.CD007655.pub3-BIB0051|cit51","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub3-BIB0052|cit52","first-page":"965","article-title":"The effect of an antihypertensive drug during psychological stress. A double-blind study","volume":"25","author":"R\u00f6sler","year":"1975","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD007655.pub3-BIB0053|cit53","first-page":"93s","article-title":"Anti-hypertensive adrenergic-blocking agents: effects on sodium balance, the renin-angiotensin system and haemodynamics","volume":"2","author":"Safar","year":"1975","journal-title":"Clinical Science and Molecular Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007655.pub3-BIB0054|cit54","first-page":"433","article-title":"Double-blind comparison of dihydralazine and prazosin in hypertensive patients on the diuretic-reserpine regimen","volume":"13","author":"Salmela","year":"1981","journal-title":"Annals of Clinical Research"},{"issue":"34","key":"10.1002\/14651858.CD007655.pub3-BIB0055|cit55","first-page":"849","article-title":"Combined uni- and multicenter double-blind studies in hypertensive patients. Comparison of blood pressure measurements","volume":"80","author":"Schmidt","year":"1991","journal-title":"Schweizerische Rundschau fur Medizin Praxis"},{"issue":"23","key":"10.1002\/14651858.CD007655.pub3-BIB0056|cit56","first-page":"915","article-title":"Reserpine plus hydrochlorothiazide and sotalol plus hydrochlorothiazide in Black and Indian hypertensive patients","volume":"65","author":"Seedat","year":"1984","journal-title":"South African Medical Journal"},{"issue":"5-6","key":"10.1002\/14651858.CD007655.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3109\/10641968909035386","article-title":"The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group","volume":"11","author":"Probstfield","year":"1989","journal-title":"Clinical and Experimental Hypertension. Part A, Theory and Practice"},{"issue":"24","key":"10.1002\/14651858.CD007655.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group","volume":"265","author":"SHEP Cooperative Research Group","year":"1991","journal-title":"JAMA"},{"issue":"12 Pt 1","key":"10.1002\/14651858.CD007655.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0895-7061(95)00363-0","article-title":"Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP)","volume":"8","author":"Kostis","year":"1995","journal-title":"American Journal of Hypertension"},{"issue":"23","key":"10.1002\/14651858.CD007655.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1001\/jama.1996.03540230036032","article-title":"Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group","volume":"276","author":"Curb","year":"1996","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD007655.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/01.STR.29.7.1333","article-title":"Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group","volume":"29","author":"Davis","year":"1998","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD007655.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/archinte.158.12.1340","article-title":"Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program","volume":"158","author":"Pahor","year":"1998","journal-title":"Archives of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD007655.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/archinte.158.7.741","article-title":"Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program","volume":"158","author":"Savage","year":"1998","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/STROKEAHA.107.500777","article-title":"Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program","volume":"39","author":"Patel","year":"2008","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cpt1969103338","article-title":"Comparative evaluation of Rauwolfia whole root and reserpine","volume":"10","author":"Smith","year":"1969","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD007655.pub3-BIB0066|cit66","first-page":"I98","article-title":"Treatment of mild hypertension: results of a ten-year intervention trial","volume":"40","author":"Smith","year":"1977","journal-title":"Circulation Research"},{"issue":"5","key":"10.1002\/14651858.CD007655.pub3-BIB0067|cit67","first-page":"243","article-title":"Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe","volume":"77","author":"Stein","year":"1990","journal-title":"South African Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000331975500600308","article-title":"Treatment of hypertension with reserpine (serpasil) alone and in combination with hydralazine (apresoline)","volume":"6","author":"Stuppy","year":"1955","journal-title":"Angiology"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub3-BIB0069|cit69","first-page":"126","article-title":"Circulatory and diuretic effects of hydrochlorothiazide and reserpine in man","volume":"1","author":"Torsti","year":"1969","journal-title":"Annals of Clinical Research"},{"key":"10.1002\/14651858.CD007655.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1749-6632.1978.tb25604.x","article-title":"Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension","volume":"304","author":"Lung","year":"1978","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"19","key":"10.1002\/14651858.CD007655.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.1982.03330190035027","article-title":"Low doses v standard dose of reserpine. A randomized, double-blind, multiclinic trial in patients taking chlorthalidone","volume":"248","author":"Veterans Administration Cooperative Study (VACS) Participants","year":"1982","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD007655.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.HYP.15.4.348","article-title":"Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study","volume":"15","author":"Materson","year":"1990","journal-title":"Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub3-BIB0073|cit73","first-page":"266","article-title":"Antihypertensive efficacy of metolazone (Zaroxolyn) alone and combined with reserpine in treatment of essential hypertension","volume":"20","author":"Hoose","year":"1976","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJM195301082480202","article-title":"The use of Rauwolfia serpentina in hypertensive patients","volume":"248","author":"Wilkins","year":"1953","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0021-9681(66)90128-7","article-title":"Effects of treatment in hypertension. Results of a controlled study","volume":"19","author":"Wolff","year":"1966","journal-title":"Journal of Chronic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD007655.pub3-BIB0076|cit76","first-page":"25","article-title":"Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?","volume":"161","author":"Wright","year":"1999","journal-title":"CMAJ"},{"issue":"2","key":"10.1002\/14651858.CD007655.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archinternmed.2007.66","article-title":"Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"168","author":"Wright","year":"2008","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007655.pub3-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001841.pub2","article-title":"First-line drugs for hypertension","author":"Wright","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007655.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T08:35:41Z","timestamp":1632213341000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007655.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,21]]},"references-count":78,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007655.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,21]]}}}